Health-Related Quality of Life in Multiple Myeloma Patients Receiving High-Dose Chemotherapy with Autologous Blood Stem-Cell Support

By Gulbrandsen N.   Wisløff F.   Brinch L.   Carlson K.   Dahl I.M.   Gimsing P.   Hippe E.   Hjorth M.   Knudsen L.M.   Lamvik J.   Lenhoff S.   Løfvenberg E.   Nesthus I.   Lanng Nielsen J.   Turesson I.   Westin J.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 65-77

Humana Press, Inc

Access to resources Recommend Favorite

Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?

By Kasper Bernd  

Supportive Care in Cancer, Vol. 12, Iss. 3, 2004-03 ,pp. : 205-207

Springer Publishing Company

Access to resources Recommend Favorite

Urinary 5-Hydroxyindoleacetic acid (5-HIAA) excretion during multiple-day high-dose chemotherapy

By Janes R.J.   Muhonen T.   Karjalainen U.P.   Wiklund T.  

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 196-198

Elsevier

Access to resources Recommend Favorite

Treatment of neuroblastoma stage 4 with 131 I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study

By Klingebiel T.   Bader P.   Bares R.   Beck J.   Hero B.   Jurgens H.   Lang P.   Niethammer D.   Rath B.   Handgretinger R.  

European Journal of Cancer, Vol. 34, Iss. 9, 1998-08 ,pp. : 1398-1402

Elsevier

Access to resources Recommend Favorite

High-dose chemotherapy with hematopoietic stem cell transplantation for the treatment of primary central nervous system lymphoma

By Campen Christopher   Tombleson Rebecca   Green Myke  

Journal of Neuro-Oncology, Vol. 101, Iss. 3, 2011-02 ,pp. : 345-355

Springer Publishing Company

Access to resources Recommend Favorite